Open Journal of Gastroenterology
Vol.4 No.6(2014), Paper ID 46969, 10
pages
DOI:10.4236/ojgas.2014.46038
Randomized, Placebo-Controlled Trial of Transdermal Rivastigmine for the Treatment of Encephalopathy in Liver Cirrhosis (TREC Trial)
Patrick P. Basu, Niraj James Shah, Mark M. Aloysius, Robert S. Brown
Columbia University College of Physicians & Surgeons, New York, USA
James J. Peters VA Medical Center, New York, USA
King’s County Hospital, New York, USA
Columbia University College of Physicians & Surgeons, New York, USA
Copyright © 2014 Patrick P. Basu, Niraj James Shah, Mark M. Aloysius, Robert S. Brown et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Basu, P. , Shah, N. , Aloysius, M. and Brown, R. (2014) Randomized, Placebo-Controlled Trial of Transdermal Rivastigmine for the Treatment of Encephalopathy in Liver Cirrhosis (TREC Trial).
Open Journal of Gastroenterology,
4, 255-264. doi:
10.4236/ojgas.2014.46038.